ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
70 hedge funds and large institutions have $200M invested in ChemoCentryx, Inc. in 2015 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 10 closing their positions.
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
12% more call options, than puts
Call options by funds: $308K | Put options by funds: $276K
11% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 19
10% more capital invested
Capital invested by funds: $183M → $200M (+$17.5M)
8% more funds holding
Funds holding: 65 → 70 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
+$3.13M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$2.53M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$1.78M |
| 4 |
A
Abingworth
London,
United Kingdom
|
+$857K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$446K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.73M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$2.29M |
| 3 |
Millennium Management
New York
|
-$2.12M |
| 4 |
Goldman Sachs
New York
|
-$1M |
| 5 |
Barclays
London,
United Kingdom
|
-$925K |
CCXI Hedge Fund Activity: Q1 2015 in Review
70 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q1 2015, worth a combined $200M — up 9.6% from $183M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new CCXI positions and 10 closed out — a net gain of 5 holders — while 21 added to existing stakes and 19 trimmed.
The largest buyer was Artal Group, adding an estimated $3.13M. The largest seller was Fidelity Investments, exiting entirely with an estimated $2.73M sold.
- 70 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q1 2015, up from 65 in Q4 2014.
- Funds reported $200M of ChemoCentryx, Inc. stock for Q1 2015, up 9.6% quarter-over-quarter.
- 15 funds opened new ChemoCentryx, Inc. positions in Q1 2015 and 10 closed out, a net change of +5 holders.
- The largest ChemoCentryx, Inc. buyer in Q1 2015 was Artal Group, an estimated $3.13M added.
- The largest ChemoCentryx, Inc. seller in Q1 2015 was Fidelity Investments, an estimated $2.73M sold.
Based on aggregated 13F filings for Q1 2015.